Detalhe da pesquisa
1.
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.
Int J Mol Sci
; 24(15)2023 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569750
2.
Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women.
Gynecol Oncol
; 146(1): 34-38, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28427775
3.
Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.
Gynecol Oncol
; 144(3): 531-535, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062116
4.
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.
Front Oncol
; 12: 789450, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35372029
5.
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
J Exp Clin Cancer Res
; 40(1): 61, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33557912
6.
Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.
Am J Cancer Res
; 10(12): 4450-4463, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415010
7.
Current First-line Therapy for Ovarian Cancer: A Comprehensive Review.
Obstet Gynecol Surv
; 73(11): 650-657, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30468240
8.
ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro.
Am J Cancer Res
; 8(8): 1551-1563, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30210923